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Monomeric Ti(IV)-based complexes incorporating
luminescent nitrogen ligands: synthesis, structural
characterization, emission spectroscopy and
cytotoxic activities†
Georges Khalil,a Christophe Orvain,b,c Lu Fang,a Laurent Barloy,a Alain Chaumont,a
Christian Gaiddon,b,c Marc Henry,a Nathalie Kyritsakasd and Pierre Mobian*a
This manuscript describes the synthesis of a series of neutral titanium(IV) monomeric complexes con-
structed around a TiO4N2 core. The two nitrogen atoms that compose the coordination sphere of the
metallic center belong to 2,2’-bipyrimidine ligands homo-disubstituted in the 4 and 4’ positions by
methyl (2a), phenylvinyl (2b), naphthylvinyl (2c) or anthrylvinyl (2d) groups. The crystal structures of these
complexes named [Ti(1)2(2a)], [Ti(1)2(2b)], [Ti(1)2(2c)] and [Ti(1)2(2d)] (where 1 is a 2,2’-biphenolato ligand
substituted in the 6 and 6’ positions by phenyl groups) are reported. The hydrolytic stability of the four
complexes is evaluated by monitoring the evolution of the free 2a–d signals by 1H NMR spectroscopy.
For the conditions tested (6 mM, DMSO-d6/D2O: 8/1), a rather good stability with t1/2 ranging from 180 to
300 min is determined for the complexes. In the presence of an acid (DCl), the hydrolysis of [Ti(1)2(2a)] is
faster than without an acid. The cytotoxic activity against gastric cancer cells of the titanium-based com-
pounds and the free disubstituted 2,2’-bipyrimidine ligands is tested, showing IC50 ranging from 6.2 ±
1.2 μM to 274 ± 56 μM. The ﬂuorescence studies of the ligands 2a–d, and the complexes [Ti(1)2(2a–d)]
reveal an important ﬂuorescence loss of the ligands 2c and 2d upon coordination with the Ti(1)2 frag-
ment. Frontier orbitals obtained by DFT calculations permit us to explain this ﬂuorescence quenching.
Introduction
Luminescence is a recurrent property displayed by transition
metal complexes.1 Luminescent transition metal complexes
are particularly attractive for applications as chemosensors,2
probes for biological molecules3 or organic light emitting
diodes.4 Luminescent transition metal complexes such as
zinc,5 copper,6 gold,7 platinum8 or d6 transition metal com-
plexes (especially ruthenium)9 have also been extensively
applied for fluorescence cell imaging.
Titanium(IV) complexes are very diverse and represent a
major class of compounds widely used in many fields of
modern molecular science. Organometallic and coordination
titanium(IV) compounds are powerful reagents for catalytic
enantioselective processes,10 organic transformations11 and as
initiators for polymerization reactions.12 Alkoxides or aryl-
oxides titanium species are precursors to generate titanium-
based materials through sol–gel processes.13 In metallo-supra-
molecular chemistry, titanium(IV) centers are intensively
employed to create self-assembled architectures from oxygen
ligands14 or from multiple components.15 Applications of tita-
nium(IV) complexes in bioinorganic chemistry are also deeply
investigated, as long as titanium(IV) is recognized for its low
toxicity for living matter. Therefore, titanium is found in many
biomaterials and numerous applications of Ti(IV) in a medical
or biological context have been described.16,17 Particularly,
titanium(IV) complexes are promising candidates for develop-
ing new anti-cancer drugs with minor side eﬀects.18,19
As we were intrigued by the rarity of reports detailing the
coordination chemistry of titanium(IV) complexes bearing
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luminescent ligands,20 this work aimed to study the ligating
properties to a titanium(IV) center of fluorescent ligands and
their resulting emissions. Thus, we report the synthesis and
the structural characterization of a series of TiO4N2-based
monomeric octahedral complexes bearing various substituted
2,2′-bipyrimidines (Chart 1). These complexes are built from
two biphenolato derivatives and one substituted 2,2′-bipyrimi-
dine unit as depicted in Fig. 1. The choice of these nitrogen
ligands is motivated by the fact that 2,2′-bipyrimidine has
shown to be a well-adapted chelate to successfully generate
TiO4N2-based complexes.
15,21 Also, 4,4′-dimethyl-2,2′-bipyrimi-
dine can be easily functionalized by various groups through
Knoevenagel reactions.22 Therefore, the synthesis of a TiO4N2-
based monomeric octahedral complex bearing 2,2′-bipyrimi-
dines substituted by “classical” fused polycyclic aromatic emit-
ters, as the naphthyl or anthryl group,23 was envisaged.
Additionally, we also detail in this manuscript some biological
applications of these Ti(IV)-based species.
Results and discussion
Synthesis of ligands and complexes
The ligands 2b–d were synthesized according to Scheme 1 in a
one-step double Knoevenagel condensation starting from the
4,4′-dimethyl-2,2′-bipyrimidine precursor 2a.22 Compound 2a
was condensed with benzaldehyde, 2-naphthaldehyde or
9-anthraldehyde using tBuOK to aﬀord the targeted bipyr-
imidine derivatives 2b–d (yields ∼ 55%). The 1H NMR spectra
for 2b–d highlighted doublets with trans vinylic coupling
(3J ∼ 16 Hz) confirming the formation of the desired bipyrimi-
dine compounds. Having in hand this set of bipyrimidine
derivatives, the synthesis of the targeted octahedral mono-
meric complexes [Ti(1)2(2a–d)] constructed around a TiO4N2
core was undertaken. The complexes were obtained by follow-
ing a well-established procedure21 based on the exchange of
the labile monodentate ligands coordinating the metal center
in [Ti(1)2(HO
iPr)2]
24 by a nitrogen bidentate ligand as pro-
posed in eqn (1).
½Tið1Þ2ðHOiPrÞ2 þ 2a–d ! ½Tið1Þ2ð2a–dÞ þ 2HOiPr ð1Þ
Complexes [Ti(1)2(2a–d)] were isolated as single crystals
suitable for X-ray analysis by dissolving in a chlorinated
solvent the [Ti(1)2(HO
iPr)2] precursor with one equivalent of
the 2a–d ligand after slow vapour diﬀusion of n-pentane. The
molecular structures of complexes [Ti(1)2(2a–d)] are shown in
Fig. 1. As expected, the structures highlight monomeric
C2-symmetric complexes incorporating an octahedral TiO4N2
unit. Interestingly, these complexes crystallize in achiral space
groups with the exception of [Ti(1)2(2a)]. [Ti(1)2(2a)] crystallizes
in the noncentrosymmetric P212121 space group when the for-
mation of the complex is performed in 1,2-dichloroethane and
n-pentane is used as a precipitant. The Λ-[Ti(1)2(2a)] enantio-
mer is observed in the analyzed crystal. The Flack parameter of
0.006(15) determined for the Λ-[Ti(1)2(2a)] structure resolution
confirms the absolute configuration attribution. Concerning
the molecular structures description, it is worth noticing that
the aromatic units substituting the bipyrimidine ligands in
[Ti(1)2(2b)] and [Ti(1)2(2c)] are coplanar to the neighbouring
pyrimidine ring. The situation is diﬀerent for [Ti(1)2(2d)] since
the two anthryl groups adopt an almost orthogonal arrange-
ment with respect to the pyrimidine rings. In all structures,
the double bonds adopt a trans isomerism as indicated by the
1H NMR analysis of the free ligands. The metrical description
of the structures is unexceptional. The Ti–O (d(Ti–O) = 1.86 ±
0.06 Å) and Ti–N (d(Ti–N) = 2.238 ± 0.004 Å) bond distances
measured in these complexes are rather similar and identical,
Chart 1
Fig. 1 Solid-state molecular structures of [Ti(1)2(2a)] (a), [Ti(1)2(2b)] (b),
[Ti(1)2(2c)] (c) and [Ti(1)2(2d)] (d). Ti atoms are in green, C atoms in black,
O atoms in red, N atoms in blue. Hydrogen atoms are omitted for clarity.
Scheme 1 General synthetic scheme followed to generate compounds
2b–d.
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respectively. The coordination polyhedra found in these
structures are distorted as attested by the mean angles
measured around the titanium atoms (N–Ti–N = 71.4° ± 1.2,
O–Ti–O(O trans to N) = 111.3° ± 1.6). We also notice in [Ti(1)2(2d)]
that the two anthryl groups are rather distant from one
another, as the closest C–C distance measured between the
two anthryl units is found to be d(Canthryl–Canthryl) = 6.66 Å.
Hydrolytic stability
Owing to the poor or moderate hydrolytic stability usually
observed for molecular Ti(IV) species such as classical anti-
cancer titanium-based compounds like budotitane and titano-
cene dichloride,25a–c the behaviour of compounds [Ti(1)2(2a–d)]
towards hydrolysis has been evaluated by following a
methodology similar to the one already reported for titanium
complexes.25d–f These studies were conducted by 1H NMR ana-
lysis of solutions in DMSO-d6 of the [Ti(1)2(2a–d)] complexes
over time, upon addition of D2O at room temperature. For
these analyses, a large amount of D2O (1000 equivalents versus
the complex) was added to the complex solution so that a final
complex solution concentration of 6 mM was obtained. It
should be noted first that when the concentration of the
complex solutions was doubled, an orange precipitate formed
instantaneously, reflecting the moderate solubility of these
species in polar media. Secondly, when the same experiment
was performed without D2O, a slight degradation of the initial
complex was noticed in DMSO. Next, the resulting 6 mM
samples were analyzed by 1H NMR. The evolution of the mix-
tures composition was monitored for [Ti(1)2(2a)], [Ti(1)2(2b)]
and [Ti(1)2(2c)] by integrating the bipyrimidine 6,6′ proton
resonances for the complex and for the free diimine ligand.
For compound [Ti(1)2(2d)], the situation was diﬀerent, as the
vinylic proton signals were monitored. The integration plots of
these signals overtime for complexes [Ti(1)2(2a–d)] are shown
in Fig. 2. The complete transformation of the complexes over a
period of time of more than 16 hours is not observed. By ana-
lyzing the mixtures after one week of their preparation, the
presence of a not negligible amount of the starting complexes
is still noticed. Also, the absence of free 2,2′-biphenol deriva-
tive in solution is confirmed. Therefore, the formation of
titanium(IV) oxo-aggregates incorporating 1 through an olation
or oxolation reaction mechanism could be envisaged since
oxo-clusters are common products when low nuclearity
titanium(IV) complexes react with water.26 The presence of
novel species formed upon hydrolysis in solution is confirmed
by NMR analysis. The aromatic region of the 1H NMR spec-
trum indicates broad signals diﬀerent from the 1H NMR signa-
ture of 1-H2. ES-MS analysis of an aliquot also proves the for-
mation of unknown hydrolytic products displaying molecular
weights not compatible with the initial complex and the free
ligands (see the ESI†). Plotting ln[complex] or 1/[complex] with
respect to time indicated highly complex kinetics for these
hydrolytic processes. The t1/2 values found for these experi-
ments demonstrated significant diﬀerences between each reac-
tion (Table 1). Complex [Ti(1)2(2a)] exhibits a faster hydrolysis
rate compared to [Ti(1)2(2b)], [Ti(1)2(2c)] or [Ti(1)2(2d)].
A linear relationship was found between these t1/2 values and
the volumes of the bipyrimidine ligands were computed from
the crystal structures of [Ti(1)2(2a–d)] with the PACHA soft-
ware27,28 as shown in Fig. 3. This relationship reveals the
shield eﬀect played by the aromatic groups substituting the
Fig. 2 Plots of the integration of the bipyrimidine 6,6’ proton signals
related to the bound diimine ligands and the free ligands for complexes
[Ti(1)2(2a)], [Ti(1)2(2b)] and [Ti(1)2(2c)]. For compound [Ti(1)2(2d)], the
vinylic proton signals were monitored. In these experiments, D2O (50 μl)
was added to the solution of the complex in DMSO-d6 to give a ﬁnal
complex concentration of 6 mM. The blue, yellow, green and red
dots correspond to the measurements made for [Ti(1)2(2a)], [Ti(1)2(2b)],
[Ti(1)2(2c)] and [Ti(1)2(2d)], respectively. Dots are the integrations corres-
ponding to the coordinated diimine ligands, squares are the integrations
of the free bipyrimidine ligands. The t1/2 values of hydrolysis calculated
from these plots are compiled in Table 1.
Table 1 t1/2 Values determined for the hydrolytic processes. Ligand
volumes computed from the crystal structures [Ti(1)2(2a–d)]
t1/2 (min) (±5%)
Volume of ligands
2a–d (Å3) (±10%)
[Ti(1)2(2a)] 180 163
[Ti(1)2(2b)] 250 320
[Ti(1)2(2c)] 270 406
[Ti(1)2(2d)] 300 498
Fig. 3 Plot of the t1/2 values determined for [Ti(1)2(2a–d)] in the course
of the hydrolytic stability studies vs. the molecular volumes of 2a–d cal-
culated from the [Ti(1)2(2a–d)] crystal structures.
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bipyrimidine ligands against water. Next, the role played by an
acid on the complex [Ti(1)2(2a)] stability was examined by
repeating the hydrolysis experiment in the presence of DCl
(38 wt% in D2O). It appears that with DCl, the transformation
of the starting [Ti(1)2(2a)] complex is nearly quantitative after
10 hours for the two DCl concentrations tested as shown in
Fig. 4. With an excess of DCl (9 equivalents versus [Ti(1)2(2a)]),
the t1/2 value of the complex is divided by two in comparison to
an experiment conducted with 1.8 equivalent of DCl vs.
[Ti(1)2(2a)]. Altogether, with an acid, the disappearance of the
complex is faster than the same reaction performed without DCl.
Photophysical analyses
To the best of our knowledge, there are very few reports of
titanium(IV) coordination complexes that would be photolumi-
nescent in solution at room temperature, if we exclude
titanium phthalocyanines, which are very specific species.29
Yet some other group 4 metal complexes (Zr, Hf) exhibit such
properties.30 However, the luminescence of several Ti com-
plexes at 77 K has been investigated.31 Besides, substituted
pyrimidines are a class of organic molecules, which often
display light-emitting properties in solution at ambient temp-
erature, and which have even been considered as candidates
for OLEDs.32 Unsubstituted 2,2′-bipyrimidine has been used
as a bridging ligand in photoluminescent binuclear lantha-
nide complexes.33 Moreover, various substituted 2,2′-bipyr-
imidines and their coordination complexes have been reported
in the literature, which display interesting photophysical pro-
perties (fluorescence and non-linear optics).34
In the present section, we describe the optical properties,
viz. absorption and emission spectroscopy, of solutions in di-
chloromethane of the ligands 1-H2 and 2a–d, and of the
derived titanium complexes [Ti(1)2(2a–d)]. The data obtained
in solution at room temperature are presented in Fig. 5 and 6
and summarized in Table 2. Incidentally, the UV-vis spectrum
of 1-H2 has been reported in the literature, but in a diﬀerent
solvent.35
Overall, the compounds absorb UV-vis light over the
240–500 nm range. The λmax value of compound 2a in CH2Cl2
(244 nm) is close to the value reported in EtOH (248 nm).36
A significant bathochromic shift is observed for the phenylvinyl-
substituted bipyrimidine 2b, in agreement with an extended
Fig. 4 Plots of the integration of the bipyrimidine 6,6’ proton signals
related to the bound diimine ligands (dots) and the free ligands (squares)
in the spectra of [Ti(1)2(2a)]. The red curves correspond to the measure-
ment made for a solution of [Ti(1)2(2a)] in DMSO-d6 (450 μl) where D2O
(50 μl) was added. The green and blue curves correspond to the
measurements made for a solution of [Ti(1)2(2a)] in DMSO-d6 (450 μl)
where D2O and DCl were added (50 μl in total for the volume of D2O
and DCl). The green curves correspond to the experiment conducted
with 2.5 μl of DCl solution (38 wt% in D2O) whereas the blue curves
correspond to the experiment conducted with 0.5 μl of DCl solution
(38 wt% in D2O). t1/2 = 67 min ± 5% for the experiment conducted with
2.5 μl of DCl; t1/2 = 138 min ± 5% for the experiment conducted with
0.5 μl of DCl.
Fig. 5 UV-visible absorption spectra of compounds 1-H2 (black), 2a
(red), [Ti(1)2(2a)] (blue), 2b (green) and [Ti(1)2(2b)] (pink) recorded at
room temperature in CH2Cl2 (concentration range: 9–55 µM).
Fig. 6 UV-visible absorption spectra of compounds 1-H2 (black), 2c
(red), [Ti(1)2(2c)] (blue), 2d (green) and [Ti(1)2(2d)] (pink) recorded at
room temperature in CH2Cl2 (concentration range: 2–18 µM).
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electronic delocalization. The spectrum of 2c exhibits several
bands of similar intensities, ranging from 276 to 365 nm; strik-
ingly, the UV-vis spectrum of a reported bis(naphthylvinyl)-
substituted pyrimidine also exhibits signals at 276 and 332 nm
with comparable absorption coeﬃcients.22b Following the
interpretation of Le Bozec et al. with regard to other related
molecules, viz. tetrakis(arylvinyl)-substituted bipyrimidines,22a
these absorptions can be assigned to intramolecular charge
transfer (ICT) from the phenyl or naphthyl group towards the
electron-deficient bipyrimidine nucleus. This statement is sup-
ported by the coplanarity of each aryl group with a vinyl bridge
and with the pyrimidine cycle, which is observed on the X-ray
structures shown in Fig. 1 (assuming that coordination to tita-
nium does not aﬀect the conformation of the ligand); this
coplanarity allows a delocalization of the π electrons. However,
as far as [Ti(1)2(2b)] and [Ti(1)2(2d)] bear only two substituents
instead of four, and as the aryl groups bear no donor atom,
the transitions that we observe lie at a higher energy than the
reported transition.22a
Finally, the absorption spectrum of compound 2d contrasts
with that of 2b and 2c, with an intense blue-shifted band at
256 nm (probably assigned to a vinylpyrimidine-centered tran-
sition) and less intense bands at 354, 372 and 392 nm. The
pattern of the latter is reminiscent of the absorption spectrum
of anthracene itself.37a Therefore, the spectrum of 2d suggests
the absence of electronic connection with the anthracene moi-
eties and the rest of the molecule. Again, this is in agreement
with the conformation of this crystal structure of the titanium
derivative [Ti(1)2(2d)] (Fig. 1) where the anthryl mean planes
make an angle of 67.25° with the vinyl planes.
The UV-vis spectra of the complexes [Ti(1)2(2a–d)] display
various intense bands (4.13 < log ε < 5.33) between 244 and
433 nm that can be reasonably assigned to ligand-centered (π→ π*)
transitions. For complexes [Ti(1)2(2c)] and [Ti(1)2(2d)], the
pattern of the free ligands 2c and 2d is roughly reproduced
(Fig. 6). In addition, they exhibit a very broad and less intense
band; this band is often obscured by the other transitions, but it
is revealed by its tail in the visible region (roughly up to 520 nm)
and is responsible for the red or orange color of the solutions. In
the case of complex [Ti(1)2(2a)], it is fairly detectable and is cen-
tered at ca. 380 nm. It can be assigned to an aryloxide-to-Ti
LMCT transition, in agreement with the literature data.30d,38
The photoluminescence analyses were conducted at low
concentrations in order to avoid self-absorption eﬀects.
Compound 1-H2 exhibits a strong luminescence at 353 nm
with a quantum yield slightly lower than 10%. In comparison,
the light-induced emission properties of phenol-derived
organic molecules related to compound 1-H2 have been
reported.39 Ligand 2a is not light-emissive in solution at RT,
which is not surprising because 2,2′-bipyrimidine is not
either;33a it is noteworthy that even the π-delocalized 4,4′-
diphenyl-6,6′-dimethyl-2,2′-bipyrimidine ligand is not photo-
luminescent at room temperature.34a 2b is only slightly emis-
sive, and the corresponding titanium complexes [Ti(1)2(2a)]
and [Ti(1)2(2b)] are not. Conversely, and as we expected, the
2-naphthyl and 9-anthryl-substituted ligands 2c and 2d are
characterized by distinct emission signals respectively centered
at 411 and 525 nm (Table 2 and Fig. 7). It is again interesting
to compare the luminescence properties of these 4,4′-di(aryl-
vinyl)-2,2′-bipyrimidines with those of related compounds: 4,6-
Table 2 Photophysical data of the ligands and titanium complexesa
Compound
Absorption Photoluminescence
λmax/nm (log ε)
b λexcitation/nm Emission: λmax/nm (Φ)
1-H2 239 (4.62), 291 (4.07) 290 353 (9 × 10
−2)
2a 244 (4.17) — —c
2b 315 (4.26) 315 405 (n.d.d)
2c 276 (4.50), 287 (4.49), 332 (4.55), 350sh (4.42), 365sh (4.23) 332 411 (6 × 10−3)
2d 256 (5.35), 354sh (3.94), 372 (4.14), 392 (4.20) 392 525 (7 × 10−3)
[Ti(1)2(2a)] 245 (4.90), 312sh (4.26), 380sh (3.73) — —
c
[Ti(1)2(2b)] 244 (4.97), 323 (4.80) — —
c
[Ti(1)2(2c)] 244 (5.08), 280sh (4.88), 293sh (4.81), 334 (4.82), 380sh (4.72) 380 477 (<10
−3)
[Ti(1)2(2d)] 253 (5.33), 365sh (4.13), 385sh (4.20), 433 (4.32) 365 490 (<10
−3)
a Conditions: solutions in dichloromethane at room temperature (concentration range: absorption = 9–55 µM; emission = 1–3 µM); Φ = quantum
yield; sh = shoulder. b ε in M−1 cm−1. cNot photoluminescent. dNot determined (very weak luminescence).
Fig. 7 Normalized excitation spectrum (λem = 525 nm, blue) and emis-
sion spectrum (λexc = 392 nm, red) of compound 2d recorded at room
temperature in CH2Cl2 (concentration: 1.91 µM).
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di(arylvinyl)pyrimidines, with aryl = 2-naphthyl or 9-anthryl,
respectively, emitting at λmax = 424 and 525 nm;
22b or 4,4′,6,6′-
tetra(arylvinyl)-2,2′-bipyrimidines (aryl = N,N-disubstituted
aminophenyl), mentioned above, whose emissions are red-
shifted with respect to our data.22a With regard to quantum
yields, 2c and 2d are less emissive (0.6 and 0.7%) than these
species, especially the latter. We also note that under aerobic
conditions, the quantum yield of anthracene itself reaches
21%, whereas it is much lower with 4,6-di(anthrylvinyl)pyr-
imidine (2%) or with 2d; obviously the pyrimidine ring(s)
partly quench the fluorescence of anthracene.
Of the four titanium complexes [Ti(1)2(2a–d)], only
[Ti(1)2(2c)] and [Ti(1)2(2d)] exhibit an emission, which is very
weak, so that the quantum yields cannot be accurately deter-
mined; several excitation wavelengths were tested before we
could detect a significant signal. Therefore, it appears that
coordination to titanium(IV) quenches the fluorescence of the
ligands almost completely. The emission band of compound
[Ti(1)2(2c)] undergoes a bathochromic shift with regard to 2c
(Δλmax = 66 nm), while [Ti(1)2(2d)] is blue-shifted by Δλmax =
35 nm with regard to 2d. Overall, the lifetimes of the excited
states are very low, within a 0.1–10 ns range (see the ESI†). In
addition, we checked that degassing a solution of [Ti(1)2(2d)]
has no influence on the emission (which remains very weak),
excluding thus any interaction with dioxygen. These data are
in agreement with a fluorescence process (singlet excited
states). The excitation spectra corresponding to the emission
maxima reported in Table 2 were recorded and were usually in
agreement with absorption spectra, with regard to the wave-
length maxima observed in the spectra (compounds 1-H2, 2c,
2d, [Ti(1)2(2c)]). The fit was not as good for compound
[Ti(1)2(2d)], but many overlapping transitions were observed in
the absorption spectrum; it is possible that some would be
emissive and others would not.
DFT calculations, frontier orbitals and discussion
In addition to the experimental optical and emission pro-
perties evaluation, the frontier orbitals of the ligands and the
complexes were computed using DFT calculations with the
B3LYP hybrid functional and cc-pVTZ basis functions.
Calculations were performed with the GAUSSIAN09 Revision
D01 software.40 Energies associated with these frontier orbitals
are listed in Table 3. First of all, for the ligands an excellent
match is found between the HOMO–LUMO gaps and the lower
energy bands characterized by UV-visible absorption spec-
troscopy. The HOMO and LUMO representations obtained for
the ligands 2a–d are shown in Fig. 8. For ligands 2b and 2c,
the HOMOs and the LUMOs are localized on one half of the
molecules, indicating an electronic communication between
the pyrimidine unit and the cyclic aromatic hydrocarbon part
of the molecules. The situation is diﬀerent for ligand 2d, as
the HOMO and to a lesser extent the LUMO are almost centred
on the anthryl fragment. This is in good agreement with the
2d absorption spectrum in the region between 350 nm and
450 nm, which resembles strongly the spectrum of anthracene
(vide supra). This originated from a tilted arrangement of the
anthryl units related to the pyrimidine units in 2d, as shown
in the [Ti(1)2(2d)] crystal structure (Fig. 1). Concerning frontier
orbitals of the complexes shown in Fig. 9, similar tendencies
are noticed between each complex. All HOMOs and HOMO−1
are localized on the substituted biphenolato ligand (HOMO−1
are given in the ESI†). The LUMOs are all centred both on the
metal and the nitrogen ligands. Indeed, the simple inspection
of HOMOs, HOMO−1 and LUMO orbitals do not permit us to
give clues about the origin of the emission properties modu-
lations of 2c and 2d upon coordination to the titanium(IV)
center. However, the examination of deeper orbitals for
[Ti(1)2(2c)] and [Ti(1)2(2d)] is much more enlightening (the
representations of the [Ti(1)2(2c)] HOMO−6 and HOMO−7 are
given in the ESI†). For [Ti(1)2(2d)] as shown in Fig. 10, the
anthryl fragments start to be involved for the HOMO−2 since
the HOMO and the HOMO−1 are only centered on the
biphenolato ligands. Furthermore, the energies associated
with these orbitals are given in Table 4. Herein, an excellent
match is found between the theoretical wavelength corres-
ponding to the ΔE(LUMO–HOMO−2) and the λmax determined
experimentally in the visible region (λ(calcd) = 438 nm, λ(exp) =
433 nm). Therefore, it can be reasonably proposed that upon
Table 3 LUMO+1, LUMO, HOMO, HOMO−1 energies for ligands 2a–d and complexes [Ti(1)2(2a–d)]
2a (eV) 2b (eV) 2c (eV) 2d (eV)
LUMO+1 −1.152 −2.103 −2.163 −2.305
LUMO −1.599 −2.202 −2.319 −2.327
HOMO −6.591 −6.227 −5.981 −5.465
HOMO−1 −7.013 −6.333 −6.024 −5.503
Δ(LUMO–HOMO)a 4.992 4.025 3.662 3.138
[Ti(1)2(2a)] (eV) [Ti(1)2(2b)] (eV) [Ti(1)2(2c)] (eV) [Ti(1)2(2d)] (eV)
LUMO+1 −2.169 −2.633 −2.684 −2.722
LUMO −2.695 −2.922 −2.978 −2.903
HOMO −5.552 −5.439 −5.400 −5.487
HOMO−1 −5.580 −5.464 −5.453 −5.489
Δ(LUMO–HOMO) 2.857 2.517 2.422 2.584
a Corresponding values of λ: 2a, 248 nm; 2b, 308 nm; 2c, 338 nm; 2d, 395 nm. The experimental values of λ are: 2a, 244 nm; 2b, 315 nm; 2c,
332 nm; 2d, 392 nm.
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excitation, an excited state is gained through the electronic
promotion of an electron of a 2d-centered occupied orbital to
the 2d-centered LUMO orbital. As the 1-centered HOMO orbi-
tals lie between the HOMOs and the LUMO involving 2d, the
fluorescence loss of 2d upon coordination is explained by an
electron transfer of one electron of the 1-centered HOMO to
the hole in the 2d-centered HOMOs. Transfer of the initially
excited electron to the hole in the 1-centered HOMO follows
this step. This intramolecular photoinduced electron transfer
(PET) mechanism41 is shown in Fig. 11. An identical PET
mechanism is proposed to explain the fluorescence quenching
in [Ti(1)2(2c)]. For [Ti(1)2(2c)], an excellent match is also found
between the experimental λmax (380 nm) and the wavelength
λ(calcd) = 369 nm associated with the gap determined between
the frontier orbitals centered on the naphthyl fragment
(LUMO–HOMO−6).
Biological properties
As mentioned above, a promising issue for Ti(IV) complexes
concerns some applications in biology and more particularly
as antitumor agents. Therefore, the biological activity of the
titanium-based compounds was tested on cell viability in the
Fig. 10 HOMO−1, HOMO−2, HOMO−3 and HOMO−4 representations
of the [Ti(1)2(2d)] complex.
Fig. 8 HOMO and LUMO representations for ligands 2a–d.
Fig. 9 HOMO and LUMO representations for complexes [Ti(1)2(2a–d)].
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AGS gastric cancer cells. The cells were treated for 48 hours
with increased concentrations of the drugs ranging from 1 to
200 µM (Fig. 12). The compounds were first solubilized in
DMSO at a concentration of 10 mM for [Ti(1)2(2a)] and 2.5 mM
for [Ti(1)2(2b)], [Ti(1)2(2c)] and [Ti(1)2(2d)] before a final
dilution in the culture medium. The cell viability was
measured using MTT assay. [Ti(1)2(2a)] showed a moderate
reduction of AGS viability reaching the IC50 at about 200 µM.
In contrast, [Ti(1)2(2b)], [Ti(1)2(2c)] and [Ti(1)2(2d)] caused a
marked diminution of cell viability already at 75 µM. Higher
doses of [Ti(1)2(2b)], [Ti(1)2(2c)] and [Ti(1)2(2d)] were not poss-
ible to test due to the poor solubility of these compounds in
DMSO and the toxic eﬀect of high doses of DMSO. The con-
centrations able to reduce by 50% the cell viability (IC50) were
determined using as maximal eﬀect wells with no cells alive
due to high cisplatin doses (Fig. 13) in order to compare the
relative cytotoxicity of the various drugs. Systematically, the
impact of DMSO alone was tested in parallel, and its lack of
toxicity checked at the concentrations of the tests. Similar IC50
results were obtained when the drugs were incubated in a
medium for 4 hours and before a fresh medium without drugs
was replaced for the remaining 44 hours before MTT assay.
These results indicate that the structure of the titanium
complex has a direct impact on the biological activity of the
compound.
To follow the localization of the compounds in cells, we
incubated for 4 hours the compounds with AGS cells and we
observed the fluorescence of the compounds under a fluo-
rescent microscope (Fig. 14a). We compared the cells treated
Fig. 11 Mechanism for PET explaining the luminescence quenching of
2d in [Ti(1)2(2d)]. A similar mechanism is proposed concerning the
luminescence quenching of 2c in [Ti(1)2(2c)].
Fig. 12 Titanium complexes reduce AGS gastric cancer cells viability.
AGS cells were treated with increasing concentration of the titanium
complex ranging from 1 µM to 200 µM for 48 hours; (a) [Ti(1)2(2a)], (b)
[Ti(1)2(2b)], (c) [Ti(1)2(2c)], (d) [Ti(1)2(2d)]. Cell viability was assessed by
MTT assay. Graphs represent mean (n = 8) with standard deviation of
one representative experiment (n = 3). *p < 0.01 as calculated by a one-
way ANOVA test followed by a Tukey post-test. Lines indicate IC50 calcu-
lated taking as maximal eﬀect wells with cells completely dead due to
the high dose of cisplatin. For each dose, the equivalent dose of DMSO
without a titanium compound was tested to verify the lack of toxicity
caused by DMSO.
Fig. 13 IC50 for [Ti(1)2(2a–d)] and ligands 2b–d calculated as described
in Fig. 12.
Table 4 Selected LUMO and HOMO energies for complexes [Ti(1)2(2c)]
and [Ti(1)2(2d)]. Values in bold correspond to the HOMOs centered on
the anthryl fragments and the naphthyl fragments in [Ti(1)2(2d)] and
[Ti(1)2(2c)] respectively
[Ti(1)2(2c)] (eV) [Ti(1)2(2d)] (eV)
LUMO+1 −2.684 −2.722
LUMO −2.978 −2.903
HOMO −5.400 −5.487
HOMO−1 −5.453 −5.489
HOMO−2 −5.465 −5.728
HOMO−3 −5.466 −5.737
HOMO−4 −5.887 −5.758
HOMO−5 −5.922
HOMO−6 −6.341
HOMO−7 −6.370
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with the [Ti(1)2(2d)] versus the cells treated with the fluorescent
ligand alone (2d). In both conditions, we observed fluorescent
aggregates, reflecting the poor solubility of the compound in
the medium. At a similar concentration (50 µM), the overall
fluorescence was reduced with the titanium complex compared
to the ligand alone, which is in full accordance with the con-
clusions drawn from the fluorimetric assay. At a higher magni-
fication, we observed the presence of fluorescence inside the
cells and around the nucleus labeled with the fluorescent
nucleus dye DAPI (Fig. 14b). However, at this stage, we are not
able to conclude if the complex has crossed the cellular mem-
brane and liberated the diimine ligand into the cells or if the
free ligand has been generated in the extracellular medium
before entering into the cells. Further investigations are
planned to elucidate that point.
Conclusions and perspectives
We have reported herein the synthesis, using a well-established
procedure, of a series of octahedral TiO4N2-based complexes
bearing substituted 2,2′-bipyrimidine ligands starting from
[Ti(1)2(HO
iPr)2]. Two of these complexes, i.e. [Ti(1)2(2c)] and
[Ti(1)2(2d)], incorporate fluorescent nitrogen ligands which
contain naphthyl and anthryl fragments, respectively. We have
demonstrated that the luminescent properties of 2c and 2d are
strongly aﬀected by their coordination to the Ti(1)2 unit, as a
strong fluorescence loss is observed for the [Ti(1)2(2c)] and
[Ti(1)2(2d)] complexes relative to the free nitrogen ligands. The
explanation of the emission quenching has been provided by
the examination of the HOMO and LUMO levels. We have also
noticed a rather good hydrolytic stability for these Ti(IV)-based
species that is correlated to the size of the polyaromatic substi-
tuents decorating the nitrogen ligand backbone. Interestingly,
this stability is aﬀected by the addition of an acid.
Additionally, preliminary biological studies were carried out.
The toxicity of these compounds has been evaluated, high-
lighting that the complexes and the nitrogen ligands are mod-
erately toxic. Also, we observed fluorescence inside the cells
when they were treated with the complex [Ti(1)2(2d)]. The long-
term applications of the behaviour of this family of complexes
in a medical or biological context are envisaged since pH-
responsive systems are highly attractive for developing novel
drug delivery systems or analytical tools.42 However, before
envisaging such applications, the solubility of these Ti(IV)-
based compounds in aqueous media must be significantly
improved.
Experimental part
General procedures
Bruker Avance-300 and Avance-500 spectrometers were used
for solution NMR spectroscopy analysis. Mass spectroscopy
and elemental analyses were performed at the Service
Commun d’Analyses, University of Strasbourg (France). The
electrospray analyses were performed on Micro-TOF (Bruker)
apparatus equipped with an electrospray (ES) source. The
elemental analyses were performed on a Flash 2000 (Thermo
Fisher Scientific) for C, H, and N elements. The analyzed mass
peaks refer to the most intense peaks (unless mentioned
otherwise in the discussion). 2-Chloro-4-phenyl-6 methyl-pyri-
midine, triphenylphosphine, NiCl2·6H2O, zinc powder, and
tBuOK were used as received from Alfa-Aesar or Sigma Aldrich.
All solvents were dried before use with activated 3 Å molecular
sieves. Tetrahydrofuran (THF) was dried by distillation using
sodium/benzophenone.
4,4′-Dimethyl-2,2′-bipyrimidine (2a). Under N2 protection, in
a mixture of 2-chloro-4-phenyl-6 methyl-pyrimidine (2 g,
15.56 mmol), NiCl2·6H2O (924 mg, 3.89 mmol), triphenyl-
phosphine (4.08 g, 15.56 mmol), and zinc powder (508 mg,
7.78 mmol) was added 50 mL of degassed DMF. The mixture
was heated at 70 °C overnight. The resulting dark red solution
was poured into a solution of 2 M aqueous ammonia
(100 mL). The solution was extracted in the first place with
diethyl ether to eliminate triphenylphosphine residues and
then with CH2Cl2. The organic layer (CH2Cl2) was combined
and evaporated to dryness. The resulting yellow solid was puri-
fied by flash chromatography on a silica gel using CH2Cl2/
MeOH (97/3) as an eluent, which provided BpymMe as a yellow
solid (704 mg, 68% yield). 1H NMR (CDCl3, 500 MHz): δ (ppm)
8.82 (d, J = 4.5 Hz, 2H), 7.24 (d, J = 2.7 Hz, 2H), 2.69 (s, 6H);
Fig. 14 AGS cells were treated with [Ti(1)2(2d)] containing a ﬂuorescent
ligand or with the ligand alone (2d) at 50 µM for 4 hours (a) or with
DMSO (NT). Cells were then observed under a microscope in a bright
ﬁeld (a, top panels) or at excitation 433 nm and emission 532 nm and
461 nm (a, bottom panels and b). (b) Bottom panels show magniﬁcations
of cells treated with [Ti(1)2(2d)] (in green) and labelled with DAPI to visu-
alize nuclei (in blue).
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13C NMR (CDCl3, 125 MHz): δ (ppm) 168.6, 162.5, 157.6, 121.1,
24.7. Mp = 117 °C; Anal. Calcd for C10H10N4: C% 64.50 N%
30.09 H% 5.41; found C% 64.40, N% 30.01, H% 5.33. MS (ESI)
m/z calcd for [2a + Na]+ = 209.0803 found 209.0790.
Preparation of bipyrimidine compounds – general pro-
cedure. Under N2 protection, 4,4′-dimethyl-2,2′-bipyrimidine
(50 mg, 0.218 mmol) was dissolved in distilled THF (20 mL) in
a bicol flask at −78 °C. tBuOK (90 mg, 0.8 mmol) was slowly
added, the solution turned brown after a few minutes. Then
the aldehyde derivative (2.3 equiv.) was added in small por-
tions. After 10 min, the mixture was stored at room tempera-
ture for 1 h. Then, 10 mL of water was added to the solution
and the THF was evaporated. The precipitate was removed by
filtration. The resulting solid was purified by flash chromato-
graphy using CH2Cl2/MeOH (97/3) as an eluent.
4,4′-Di((E)-styryl)-2,2′-bipyrimidine (2b). Yield = 58%. 1H
NMR (CD2Cl2, 500 MHz): δ (ppm) 8.93 (d,
3J = 3.9 Hz, 2H), 8.02
(d, 3J = 16.1 Hz, 2H), 7.70 (m, 4H), 7.51 (d, 3J = 5 Hz, 2H),
7.45–7.37 (complex, 6H), 7.29 (d, 3J = 16.0 Hz, 2H). 13C NMR
(CD2Cl2, 125 MHz): δ (ppm) 163.5, 162.8, 157.8, 137.9, 135.7,
129.6, 129.0, 127.8, 126.0, 118.0. Mp = 214 °C. Anal. Calcd for
C24H18N4·1/3CH2Cl2: C% 74.80, N% 14.34, H% 4.82; found
C% 75.47, N% 13.42, H% 4.97. MS (ESI) m/z calcd for [2d + H]+
= 363.1531 found 363.1587.
4,4′-Bis((E)-2-(naphthalen-2-yl)vinyl)-2,2′-bipyrimidine (2c).
Yield = 55%. 1H NMR (CDCl3, 500 MHz): δ (ppm) 8.99 (d,
3J =
4.7 Hz, 2H), 8.12 (d, 3J = 16.5 Hz, 2H), 8.05 (s, 2H), 7.88
(m, 8H), 7.59 (d, 3J = 5.2 Hz, 2H), 7.51 (m, 4H), 7.47 (d, 3J =
16.5 Hz, 2H). 13C NMR (CDCl3, 125 MHz): δ (ppm) 164.1,
163.0, 158.3, 138.2, 134.0, 133.5, 133.2, 129.3, 128.8, 128.5,
127.8, 127.0, 126.7, 126.6, 123.6, 117.6. Mp = 227 °C. Anal.
Calcd for C32H22N4·CH2Cl2: C% 72.40 N% 12.95 H% 4.42;
found C% 72.49, N% 12.36, H% 4.90. MS (ESI) m/z calcd for
[BpymNapht + Na]+ = 485.1742 found 485.1699.
4,4′-Bis((E)-2-(anthracen-9-yl)vinyl)-2,2′-bipyrimidine (2d).
Yield = 54%. 1H NMR (CDCl3, 500 MHz): δ (ppm) 9.07 (d,
3J =
5.1 Hz, 2H), 8.94 (d, 3J = 16.0 Hz, 2H), 8.44 (s, 2H), 8.36 (dd,
3J = 7.0 Hz, 4J = 1.7 Hz, 4H), 8.01 (dd, 3J = 6.0 Hz, 4J = 1.7 Hz,
4H), 7.64 (d, 3J = 5.1 Hz, 2H), 7.51 (m, 8H), 7.23 (d, 3J =
16.0 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ (ppm) 163.5,
163.3, 158.6, 135.7, 134.8, 131.4, 130.7, 129.6, 128.9, 127.9,
126.1, 125.7, 125.4, 118.2. Mp = 239 °C. Anal. Calcd for
C40H26N4·9/5CH2Cl2: C% 70.16, N% 7.83, H% 4.17; found C%
69.75, N% 7.90, H% 4.27. MS (ESI) m/z calcd for [2d + Na]+ =
585.2055 found 585.2100.
Preparation of titanium(IV) complexes – general procedure
Under N2 protection (glove bag), a counter solvent was allowed
to slowly diﬀuse into a solution containing the bipyrimidine
ligand (1 equiv.) and the cis-[Ti(1)2(HO
iPr)2] complex
24 (10 mg)
in a minimum amount of dry CH2Cl2/CHCl3 in a small vial.
Crystals were isolated by filtration.
[Ti(1)2(2a)]. Crystals were obtained from 1,2 dichloroethane/
n-pentane. C58H42N4O4Ti; T = 173(2) K; orthorhombic; space
group P2(1)2(1)2(1); a = 11.8033(3) Å, b = 16.0200(4) Å, c =
23.9080(6) Å; V = 4520.7(2) Å3; Z = 4; Dcalcd = 1.332 g cm
−3;
reflections collected: 90 802; Rint = 0.0572; R1(F) (I > 2σ(I)) =
0.0402, wR2(F
2) (all data) = 0.0917; GOF(F2) = 1.027. CCDC
number 1468167. Yield = 61%. 1H NMR (CD2Cl2, 500 MHz):
δ (ppm) 8.33 (d, 3J = 5.4 Hz, 2H), 7.44 (dd, 3J = 7.3 Hz, 4J =
3.3 Hz, 4H), 7.29 (td, 3J = 7.5 Hz, 4J = 1.9 Hz, 4H), 7.13 (dd, 3J =
7.4 Hz, 4J = 2.0 Hz, 2H), 7.09 (t, 3J = 7.6 Hz, 2H), 7.04 (m, 6H),
6.81 (dd, 3J = 8.4 Hz, 4J = 1.5 Hz, 6H), 6.73 (m, 10H), 6.66 (t,
3J = 7.4 Hz, 2H), 3.76 (s, 6H). 13C NMR (CD2Cl2, 125 MHz):
δ (ppm) 170.9, 160.7, 160.0, 157.2, 155.2, 138.8, 138.4, 131.8,
131.4, 129.8, 129.7, 129.6, 129.3, 129.1, 129.0, 128.7, 128.0,
127.5, 127.0, 126.0, 125.3, 122.1, 120.9, 119.7, 24.4. MS (ESI)
m/z calcd for [[Ti(1)2(2a)] + H]
+ = 907.27 found 907.28.
[Ti(1)2(2b)]. Crystals were obtained from CH2Cl2/n-pentane.
C72H50N4O4Ti, T = 173(2) K; monoclinic; space group P21/n;
a = 13.5432(3) Å, b = 14.0231(4) Å, c = 29.0361(8) Å; β = 93.2494
(14)°; V = 5505.6(3) Å3; Z = 4; Dcalcd = 1.307 g cm
−3; reflections
collected: 65 399; Rint = 0.0763; R1(F) (I > 2σ(I)) = 0.0606,
wR2(F
2) (all data) = 0.1947; GOF(F2) = 1.036. CCDC number
1468801. Yield = 51%. 1H NMR (CDCl3, 500 MHz): δ (ppm)
8.36 (d, 3J = 5.8 Hz, 2H), 7.81 (d, 3J = 16.1 Hz, 2H), 7.74 (d, 3J =
7.4 Hz, 4H), 7.49 (m, 10H), 7.25 (m, 4H), 7.14 (dd, 3J = 7.4 Hz,
4J = 1.4 Hz, 2H), 7.02 (m, 10H), 6.86 (m, 6H) 6.07 (m, 5H), 6.59
(m, 3H). 13C NMR (CDCl3, 125 MHz): δ (ppm) 165.3, 160.8,
160.2, 157.7, 155.5, 140.6, 138.7, 138.6, 135.2, 131.5, 131.3,
130.7, 130.4, 129.9, 129.6, 129.4, 129.3, 129.2, 129.0, 128.8,
128.2, 127.7, 127.4, 126.9, 125.9, 125.5, 125.4, 121.9, 119.4,
116.8. MS (ESI) m/z calcd for [[Ti(1)2(2b)] + H]
+ = 1083.3312
found 1083.3406.
[Ti(1)2(2c)]. Crystals were obtained from CHCl3/n-pentane.
2(C80H54N4O4Ti), C5H12; T = 173(2) K; monoclinic; space group
P21/c; a = 20.622(2) Å, b = 13.9118(16) Å, c = 23.906(3) Å; β =
96.372(4)°; V = 6816.0(14) Å3; Z = 2; Dcalcd = 1.188 g cm
−3;
reflections collected: 13 151; Rint = 0.1213; R1(F) (I > 2σ(I)) =
0.1288, wR2(F
2) (all data) = 0.3330; GOF(F2) = 1.137. CCDC
number 1468168. Yield = 47%. 1H NMR (CDCl3, 500 MHz):
δ (ppm) 8.39 (d, 3J = 5.2 Hz, 2H), 8.16 (s, 2H), 7.95 (m, 10H),
7.58 (dd, 3J = 5.2, 4J = 2.9 Hz, 4H), 7.48 (d, 3J = 7.5 Hz, 4H), 7.35
(d, 3J = 15.6 Hz, 2H), 7.28 (m, 4H), 7.16 (dd, 3J = 8.1, 4J = 1.7
Hz, 2H), 7.03 (m, 9H), 6.90 (m, 6H), 6.73 (m, 6H), 6.62 (m, 3H).
13C NMR (CDCl3, 125 MHz): δ (ppm) 170.9, 165.7, 165.4, 160.8,
160.7, 160.2, 160.1, 157.8, 157.7, 157.5, 155.5, 155.4, 155.3,
140.8, 138.8, 138.7, 138.6, 138.5, 134.3, 133.5 (2 signals), 132.7,
132.6, 131.6, 131.5, 131.3, 131.1, 130.7, 130.2, 129.9, 129.7,
129.6, 129.5, 129.4 (2 signals), 129.3, 129.2, 129.0 (2 signals),
128.9, 128.8, 128.7, 128.4, 128.3, 128.0, 127.9, 127.5, 127.4,
127.0, 126.9, 126.0, 125.9, 125.6, 125.5, 125.0, 123.6 (2 signals),
122.0, 121.9, 121.4, 120.8, 119.4, 116.7, 116.4. MS (ESI) m/z
calcd for [[Ti(1)2(2c)] + Na]
+ = 1205.3625 found 1205.3411.
[Ti(1)2(2d)]. Crystals were obtained from CHCl3/n-pentane.
4(C88H58N4O4Ti), CHCl3, 4(H2O); T = 173(2) K; monoclinic;
space group P2/c; a = 21.6458(9) Å, b = 18.2186(10) Å, c =
19.9733(11) Å; β = 112.479(2)°; V = 7278.1(6) Å3; Z = 1; Dcalcd =
1.223 g cm−3; reflections collected: 19 714; Rint = 0.0869; R1(F)
(I > 2σ(I)) = 0.0912, wR2(F
2) (all data) = 0.3117; GOF(F2) = 1.051.
CCDC number 1468169. Yield = 41%. 1H NMR (CDCl3,
500 MHz): δ (ppm) 9.14 (d, 3J = 15.8 Hz, 2H), 8.48 (m, 4H),
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8.42 (d, 3J = 7.9 Hz, 4H), 8.03 (dd, 3J = 7.9 Hz, 4J = 1.8 Hz, 4H),
7.48 (m, 12H), 7.31 (m, 4H), 7.20 (dd, 3J = 7.3 Hz, 4J = 1.2 Hz,
2H), 7.05 (m, 14H), 6.86 (m, 10H), 6.72 (t, 3J = 7.3 Hz, 2H).
Dept 13C NMR (CDCl3, 125 MHz): CH δ (ppm) 156.1, 138.1,
132.7, 131.8, 131.4, 129.9, 129.7, 129.6, 129.2, 129.0, 128.6,
127.5, 127.0, 126.6, 126.0, 125.5 (2 signals), 125.0, 122.0, 119.5,
118.0. MS (ESI) m/z calcd for [[Ti(1)2(2d)] + H]
+ = 1283.3938
found 1283.4100.
Preparation of the NMR samples for hydrolytic stability assay
without and with DCl
The preparation of the samples was conducted under an argon
atmosphere. Complexes [Ti(1)2(2a)], [Ti(1)2(2b)], [Ti(1)2(2c)]
and [Ti(1)2(2d)] were dissolved in dry DMSO-d6. Then, the
resulting solutions were transferred into an NMR tube. To
these solutions were added D2O (50 μl). The final concen-
trations were 6 mM. The NMR tubes were closed with a Teflon
cap. The final solutions were analyzed using a 600 MHz
spectrometer.
For the experiments conducted with DCl, the final concen-
trations were also 6 mM. Complex [Ti(1)2(2a)] was dissolved in
dry DMSO-d6. To this solution was added 50 μl of an aqueous
(D2O) solution of DCl. The more acidic solution contains 2.5 μl
of DCl solution (38 wt% in D2O) (3 × 10
−5 mol, 9 equivalents
versus [Ti(1)2(2a)]) whereas the second solution contains 0.5 μl
of DCl solution (38 wt% in D2O) (6 × 10
−6 mol, 1.8 equivalent
versus [Ti(1)2(2a)]).
Cell cultures
Human AGS gastric cancer cells were obtained from ATCC.
AGS cells were manipulated and cultured in DMEM with 10%
FCS (Dominique Dutcher™) and 1% penicillin + streptomycin
(Sigma) at 37 °C under a 5% CO2 atmosphere as previously
described.43
Cell survival
5000 cells were seeded per well in 96-well microplates (Falcon
Multiwell), 24 hours prior to any treatment. The complexes
were applied for 48 h in fresh medium. MTT assay was per-
formed as previously described by replacing the medium with
a fresh medium supplemented with 5 mg L−1 MTT (Sigma) for
1 h.44 The cells were lysed in isopropanol with 0.04 N HCl.
Measurements were performed at 550 nm. IC50 were calculated
using as maximal value wells with complete loss of cell survi-
val due to the high dose of cisplatin (50 µM).
Microscopy
The cells were grown on cover glasses in a growth medium and
incubated for 4 hours with the complexes at various dilutions.
The cells were then incubated with DAPI (Thermo Fisher) for
15 min. After incubation, the cells were observed directly
under an epifluorescence microscope (Zeiss Apotome V2 axio-
zoom) at excitation 433 nm and emission 532 nm and 461 nm
(DAPI).
X-ray crystallography
The X-ray diﬀraction data were collected on a Bruker Smart CCD
diﬀractometer with Mo-Kα radiation (λ = 0.71073 Å). The struc-
tures were solved and refined using the Bruker SHELXTL
Software Package using SHELXS-97 (Sheldrick, 2014) and refined
by full matrix least-squares on F2 using SHELXL-97 (Sheldrick,
2014) with anisotropic thermal parameters for all non-hydrogen
atoms.45 The hydrogen atoms were introduced at calculated
positions and not refined (riding model). For the structures of
compounds [Ti(1)2(2c)] and [Ti(1)2(2d)], we used the squeeze
command because the solvents could not be identified.
Photophysical measurements
The UV-visible absorption spectra were recorded using a
Perkin Elmer Lambda 650S spectrometer at room temperature
with a 1 cm path cell. The luminescence spectra were recorded
at room temperature using a Fluorolog FL3-22 spectrofluorom-
eter (Horiba Jobin Yvon) equipped with a TBX-04 or an R928
detector. All of the luminescence measurements were per-
formed on optically dilute solutions with spectrophotometry-
grade dichloromethane, with a maximum absorbance of 0.08.
For the luminescence steady-state measurements, the spectro-
meter was equipped with a 450 W xenon lamp excitation
source and excitation and emission double-grating monochro-
mators with bandpass set at 2 nm for the experiments. The
spectra were corrected for the lamp, the monochromators, and
the detector responses; blanks (solvent alone) were recorded
and subtracted from the raw spectra, unless otherwise stated.
The luminescence quantum yields were determined in spectro-
photometry-grade dichloromethane solutions using either
terphenyl in cyclohexane (Φ = 0.93, for compound 1-H2) or
quinine sulfate in aerated 0.05 M H2SO4 (Φ = 0.55, for the
other compounds) as luminescence standards.37b
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